Clinical trial
A Pilot Clinical Trial Of Memantine for Essential Tremor
NCT00439699 · VA Greater Los Angeles Healthcare System, U.S. Fed · Completed
Key facts
| NCT number | NCT00439699 |
|---|---|
| Title | A Pilot Clinical Trial Of Memantine for Essential Tremor |
| Official title | A Pilot Clinical Trial of Memantine for Essential Tremor |
| Lead sponsor | VA Greater Los Angeles Healthcare System, U.S. Fed |
| Collaborators | Ralph M. Parsons Foundation Forest Laboratories Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Essential Tremor |
| Intervention type | Drug |
| Interventions | Memantine |
| Enrollment | 16 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Feb 26, 2007 |
| Last update posted | Jun 22, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: